Incretin responses to oral glucose load in Japanese non-obese healthy subjects

Diabetes Therapy

Volumn 2, Issue 1, 2011, Pages 20-28

  Nagai, Etsuko ^a   Katsuno, Tomoyuki ^a   Miyagawa, Jun ichiro ^a   Konishi, Kosuke ^a   Miuchi, Masayuki ^a   Ochi, Fumihiro ^a   Kusunoki, Yoshiki ^a   Tokuda, Masaru ^a   Murai, Kazuki ^a   Hamaguchi, Tomoya ^a   Namba, Mitsuyoshi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

diabetes mellitus; glucagon; glucagonlike peptide 1; glucose dependent insulinotropic polypeptide; incretin; insulin

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GLUCAGON RELEASE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HUMAN; HUMAN EXPERIMENT; IMMUNOREACTIVITY; INSULIN RELEASE; JAPANESE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; VOLUNTEER;

EID: 79953178960     PISSN: 18696953     EISSN: 18696961     Source Type: Journal    
DOI: 10.1007/s13300-010-0017-1     Document Type: Article

References (26)

1. Kim W, Egan JM. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev. 2008; 60: 470-512.
2. Kelly KR, Brooks LM, Solomon TP, Kashyap SR, O'Leary VB, Kirwan JP. The glucose-dependent insulinotropic polypeptide and glucose-stimulated insulin response to exercise training and diet in obesity. Am J Physiol Endocrinol Metab. 2009; 296: E1269-E1274.
3. Vilsboll T, Krarup T, Deacon CF, Madsbad S, Holst JJ. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes. 2001; 50: 609-613.
4. Knop FK, Vilsboll T, Hojberg PV, et al. Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state? Diabetes. 2007; 56: 1951-1959.
5. Lee S, Yabe D, Nohtomi K, et al. Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes. Endocr J. 2009; 57: 119-126.
6. Kozawa J, Okita K, Imagawa A, Holst JJ, Yamagata K, Shimomura I. Similar incretin secretion in obese and nonobese Japanese subjects with type 2 diabetes. Biochem Biophys Res Commun. 2010; 393: 410-413.
7. Yabe D, Kuroe A, Lee S, et al. Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: comparison of type 2 diabetes patients and healthy controls. J. Diabetes Invest. 2010; 1: 56-59.
8. Matthews, DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-419.
9. Wareham NJ, Phillips DI, Byrne CD, Hales CN. The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med. 1995; 12: 931.
10. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfelt W. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest. 1993; 91: 301-307.
11. Cataland S, Crockett SE, Brown JC, Mazzaferri ER. Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man. J Clin Endocrinol Metab. 1974; 39: 223-228.
12. Toft-Nielsen MB, Damholt MB, Madsbad S, et al. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab. 2001; 86: 3717-3723.
13. Wishart JM, Horowitz M, Morris HA, Jones KL, Nauck MA. Relation between gastric emptying of glucose and plasma concentrations of glucagonlike peptide-1. Peptide. 1998; 19: 1049-1053.
14. Vollmer K, Holst JJ, Baller B, et al. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes. 2008; 57: 678-687.
15. Carroll JF, Kaiser KA, Franks SF, Deere C, Caffrey JL. Influence of BMI and gender on postprandial hormone responses. Obesity. 2007; 15: 2974-2983.
16. Amiel SA, Maran A, Powrie JK, Umpleby AM, Macdonald IA. Gender differences in counterregulation to hypoglycaemia. Diabetologia. 1993; 36: 460-464.
17. Galassetti P, Tate D, Neill RA, Morrey S, Davis SN. Effect of gender on counterregulatory responses to euglycemic exercise in type 1 diabetes. J Clin Endocrinol Metab. 2002; 87: 5144-5150.
18. Diamond MP, Jones T, Caprio S, et al. Gender influences counterregulatory hormone responses to hypoglycemia. Metabolism. 1993; 42: 1568-1572.
19. Fukushima M, Suzuki H, Seino Y. Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Res Clin Pract. 2004; 66S: s37-s43.
20. Meier JJ, Hucking K, Holst JJ, Deacon CF, Schmiegel WH, Nauck MA. Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes. Diabetes. 2001; 50: 2497-2504.
21. Nyholm B, Walker M, Gravholt CH, et al. Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of type II (noninsulin-dependent) diabetic parents: evidence of several aberrations. Diabetologia. 1999; 42: 1314-1323.
22. Nauck, MA, El-Ouaghlidi A, Gabrys B, et al. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes. Regul Pept. 2004; 122: 209-217.
23. Tseng CC, Boylan MO, Jarboe LA, Usdin TB, Wolfe MM. Chronic desensitization of the glucosedependent insulinotropic polypeptide receptor in diabetic rats. Am J Physiol. 1996; 270: E661-E666.
24. Holst JJ, Gromada J, Nauck MA. The pathogenesis of NIDDM involves a defective expression of the GIP receptor. Diabetologia. 1997; 40: 984-986.
25. Zhou J, Livak MF, Bernier M, et al. Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets. Am J Physiol Endocrinol Metab. 2007; 293: E538-E547.
26. Phillips WT, Schwartz JG, McMahan CA. Rapid gastric emptying of an oral glucose solution in type 2 diabetic patients. J Nucl Med. 1992; 8: 1496-1500.